Oikonomou EK, Suchard MA, McGuire DK, Khera R. Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes. Diabetes Care. 2022 Apr 1;45(4):965-974. doi: 10.2337/dc21-1765. PMID: 35120199; PMCID: PMC9016734.